Security key
58506Q109
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 26,383,560
- Total 13F value
- $8,288,435,409
- Share change
- +1,056,632
- Put/Call ratio
- 181%
- SEC-reported price per share
- $313.86
- Number of holders
- 594
- Value change
- +$333,924,731
- Number of buys
- 298
- Number of sells
- 277
- Shares outstanding
- 28,253,969
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
594
Top holders
10
MEDP full security history
Ownership snapshot
Full 13F holder table
Medpace Holdings, Inc. SEC filings
Medpace Holdings, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of MEDP - Medpace Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Medpace Investors, LLC
Disclosed value leader
Medpace Investors, LLC
Comparable rows
0/15
Latest evidence
31 Mar 2025
3/4/5
13F
Highest disclosed value: $1,934,432,195
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Medpace Investors, LLC has the largest disclosed position value at $1.93B.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Medpace Investors, LLC's linked filing trail.
Disclosed position value
Top 5
Medpace Investors, LLC
$1.93B
BlackRock, Inc.
$819.04M
VANGUARD GROUP INC
$771.96M
Invesco Ltd.
$361.6M
WASATCH ADVISORS LP
$252.73M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Medpace Investors, LLC |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$1,934,432,195
4,733,019 shares
|
— | 06 Mar 2024 |
| BlackRock, Inc. |
13F
Company
|
—
denominator unverified
|
$819,044,192
2,688,123 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$771,964,413
2,533,606 shares
|
— | 31 Mar 2025 |
| Invesco Ltd. |
13F
Company
|
—
denominator unverified
|
$361,596,344
1,186,768 shares
|
— | 31 Mar 2025 |
| WASATCH ADVISORS LP |
13F
Company
|
—
denominator unverified
|
$252,728,167
829,460 shares
|
— | 31 Mar 2025 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$238,568,004
782,986 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
594
Shares
26,383,560
Rows available
594
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
578
Q2 2025 holders
594
Holder diff
16
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|